COMMUNIQUÉS West-GlobeNewswire

Alder BioPharmaceuticals, Inc. Announces Pricing of $250 Million of 2.50% Convertible Senior Notes Due 2025
30/01/2018
BOTHELL, Wash., Jan. 29, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR ), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, announced [...]
Cannabis Wheaton Income Corp. Announces Completion of Previously Announced Debt Settlement
30/01/2018
VANCOUVER, British Columbia, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX.V:CBW) (" Cannabis Wheaton " or the " Company ") has completed the shares for debt settlement with [...]
CymaBay Announces Proposed Public Offering of Common Stock
29/01/2018
NEWARK, Calif., Jan. 29, 2018 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (Nasdaq: CBAY ), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]
Auris Medical Announces Pricing of $5.5 Million Registered Direct Offering
29/01/2018
Zug, Switzerland, January 29, 2018 - Auris Medical Holding AG ("Auris Medical", NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, [...]
Surgery Partners Announces Executive Leadership Transitions
29/01/2018
David Kretschmer appointed Chief Strategy and Transformation Officer; Executive with more than 35 years of financial and corporate strategy experience Mr. Kretschmer to serve as interim Chief Financial Officer, [...]
Vestaron Corporation is Named in the 2018 Global Cleantech 100
29/01/2018
KALAMAZOO, Mich., Jan. 29, 2018 (GLOBE NEWSWIRE) -- Vestaron Corporation, a leading developer of peptide-based bioinsecticides, today announced it was named in the prestigious 2018 Global Cleantech 100 , produced by CTG [...]
Five Prime Therapeutics Announces Closing of Upsized Public Offering
29/01/2018
SOUTH SAN FRANCISCO, Calif., Jan. 29, 2018 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq: FPRX ) announced today the closing of its upsized public offering of 5,897,435 shares of its common stock, which [...]
Eyenovia Announces Closing of $27.3 Million Initial Public Offering
29/01/2018
NEW YORK, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Eyenovia Inc. (“Eyenovia”), (NASDAQ: EYEN ), a clinical stage biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print [...]
Amarin Announces Proposed Public Offering of American Depositary Shares
29/01/2018
BEDMINSTER, N.J., and DUBLIN, Ireland, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ) today announced a registered underwritten public offering of its American Depositary Shares. All of the [...]
Albireo Announces Closing of $74.8 Million Public Offering Including Exercise of Underwriters’ Option to Purchase Additional Shares
29/01/2018
BOSTON, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO ), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, announced today the completion of its [...]
Iovance Biotherapeutics, Inc. Announces Closing of $172.5 Million Common Stock Public Offering
29/01/2018
SAN CARLOS, Calif., Jan. 29, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (Nasdaq: IOVA ), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) [...]
Diffusion Pharmaceuticals Announces First Patient Dosed in Phase 3 Trial with TSC in Inoperable Glioblastoma Multiforme
29/01/2018
CHARLOTTESVILLE, Va., Jan. 29, 2018 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN ) (“Diffusion” or “the Company”), a clinical-stage biotechnology company focused on extending the life expectancy of [...]
Misonix to Report Fiscal 2018 Second Quarter Financial Results, Host Conference Call and Webcast on February 6
29/01/2018
FARMINGDALE, N.Y., Jan. 29, 2018 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON ) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, [...]
Players Network, Inc. Selects 1-800-PublicRelations (1800pr) as Public Relations Agency of Record
29/01/2018
LAS VEGAS, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Players Network Inc. (OTCQB:PNTV), a diversified holding company operating in marijuana and media, announced today that 1-800-PublicRelations, Inc. ( 1800pr ) will serve as [...]
GW Pharmaceuticals to Report Q1 Financial Results and Host Conference Call on 5 February, 2018
29/01/2018
LONDON, Jan. 29, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH ) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its [...]
Diaxonhit - Chiffre d'affaires 2017 à 42,9 M€, en très forte progression de 55%
29/01/2018
Chiffre d'affaires 2017 à 42,9 M€, en très forte progression de 55% Chiffre d'affaires pro forma à 48,0 M€ en progression de 9% Paris, le 29 janvier 2018 - Diaxonhit (FR0013240934, ALEHT, éligible PEA-PME), groupe [...]
OnePoint Patient Care Launches OneConnectPoint
29/01/2018
MORTON GROVE, Ill., Jan. 29, 2018 (GLOBE NEWSWIRE) -- OnePoint Patient Care has introduced OneConnectPoint, the hospice industry’s most advanced medication management application. Specifically designed to meet the [...]
IBA SA : Transparence notification
29/01/2018
IBA - TRANSPARENCY NOTIFICATION Louvain-la-Neuve, Belgium, January 29, 2018, 17.35 - IBA (Ion Beam Applications SA), the world's leading provider of proton therapy solutions for the treatment of cancer, announces that [...]
IBA SA : Notification de transparence
29/01/2018
IBA - NOTIFICATION DE TRANSPARENCE Louvain-la-Neuve, Belgique, 29 janvier 2018, 17.35 - IBA (Ion Beam Applications SA), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, annonce [...]

Pages